Citius Oncology, Inc. Shareholders' Equity
Citius Oncology, Inc. (CTOR) had Shareholders' Equity of $40.38 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $40.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $35.27M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $58.41M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $44.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $40.38M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $35.27M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $58.41M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $44.87M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $32.40M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $35.64M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $41.29M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $46.14M 10-Q · filed 2026-08-14 | |
| 2024-06-30 | $17.03M 10-Q · filed 2025-08-12 | -$3.04M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $19.85M 10-Q · filed 2025-08-12 | -$2.46M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $22.73M 10-Q · filed 2025-08-12 | -$1.99M 10-K · filed 2024-04-16 |
| 2023-09-30 | $25.54M 10-K · filed 2025-12-23 | -$1.08M 10-Q · filed 2023-11-20 |
| 2023-06-30 | -$1.97K 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $197.59K 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $345.51K 10-Q · filed 2024-08-09 | |
| 2022-09-30 | $36.27M 10-K · filed 2024-12-27 | -$10.11K 10-Q · filed 2022-11-28 |
| 2022-06-30 | -$10.11K 10-Q · filed 2023-11-20 | |
| 2022-03-31 | -$10.11K 10-Q · filed 2023-11-20 | |
| 2021-12-31 | -$10.11K 10-K · filed 2024-04-16 | |
| 2021-09-30 | -$10.11K 10-Q · filed 2022-11-28 | |
| 2021-06-30 | -$10.11K 10-Q · filed 2022-11-28 | |
| 2021-03-31 | -$9.39K 10-Q · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |